• EPI-001: A Next-Generation Inhibitor for Androgen Receptor S

  2026-05-16

  Explore the advanced capabilities of EPI-001, a leading androgen receptor N-terminal domain inhibitor, in overcoming resistance in prostate and triple-negative breast cancer models. This article uniquely analyzes mechanistic insights and assay implications to inform translational research.

• Ruxolitinib (INCB018424): Optimized Workflows in Myeloprolif

  2026-05-15

  Ruxolitinib (INCB018424) enables precise, reproducible inhibition of JAK-STAT signaling in translational myeloproliferative disorder research. This article details actionable protocol enhancements, robust troubleshooting strategies, and unique workflow advantages that distinguish Ruxolitinib as an indispensable tool for dissecting oncogenic JAK2 fusion protein pathways.

• Dabigatran etexilate: Direct Thrombin Inhibitor for Anticoag

  2026-05-15

  Dabigatran etexilate is a potent, selective oral direct thrombin inhibitor that offers predictable anticoagulant effects without the need for routine coagulation monitoring. Its nanomolar affinity for thrombin makes it highly effective in both in vitro and in vivo research models. The compound is widely used in studies focused on stroke prevention in atrial fibrillation and the modulation of the coagulation cascade.

• Sodium Overload Impairs Mitochondrial Function via NECSO Pat

  2026-05-14

  Qiao et al. reveal that sodium influx disrupts mitochondrial energy metabolism, driving necrosis through the NECSO pathway. Their mechanistic study connects TRPM4-mediated sodium entry to mitochondrial dysfunction and energy failure, with broad implications for cell death research and mitochondrial function analysis.

• FH1 Small Molecule: Transforming iPS Cell Hepatocyte Differe

  2026-05-14

  FH1 small molecule enables robust maturation of iPS cell-derived hepatocytes, offering reproducible increases in albumin secretion and functional markers for liver cell research. Discover how optimized workflows and troubleshooting strategies with FH1 (Catalog No. B3700) can elevate hepatocyte-like cell cultures for advanced applications, from drug metabolism to gene therapy models.

• Protein A/G Magnetic Beads: Precision in Protein Interaction

  2026-05-13

  Protein A/G Magnetic Beads streamline immunoprecipitation workflows, offering unmatched specificity for capturing antibody-antigen complexes from complex samples. Their recombinant design reduces background and enhances reproducibility, making them a superior choice for protein-protein interaction and chromatin studies.

• Technical Guide: Angiotensin I/II (1-5) in RAS Research Work

  2026-05-13

  Angiotensin I/II (1-5) provides a defined Asp-Arg-Val-Tyr-Ile peptide fragment for precise modeling of the renin-angiotensin system, supporting studies in blood pressure regulation and aldosterone signaling. Its use is limited to cardiovascular and renal research; it should not be applied outside these parameters due to specific solubility and biochemical constraints.

• Geneticin (G-418 Sulfate): Advanced Selection and Antiviral

  2026-05-12

  Explore the dual roles of G418 Sulfate (Geneticin) as a selection antibiotic and antiviral tool. Discover new scientific perspectives linking ribosomal inhibition to cell metabolism, and gain actionable protocol guidance for genetic engineering and Dengue virus research.

• Liproxstatin-1 HCl: Optimizing Ferroptosis Assays and Models

  2026-05-12

  Liproxstatin-1 HCl, a nanomolar ferroptosis inhibitor from APExBIO, empowers researchers to dissect iron-dependent cell death with exceptional selectivity in both cellular and animal models. This guide translates the latest mechanistic breakthroughs into actionable workflows and troubleshooting strategies for acute renal failure and hepatic ischemia/reperfusion injury studies.

• Hesperadin: Precision Aurora B Kinase Inhibitor for Cell Cyc

  2026-05-11

  Hesperadin, a potent Aurora B kinase inhibitor from APExBIO, offers unmatched specificity for dissecting mitotic progression and spindle assembly checkpoint dynamics. This guide delivers experimental workflows, actionable troubleshooting, and advanced assay insights to accelerate translational cancer research and cell cycle studies.

• LLY-507: Advanced SMYD2 Inhibitor Workflows for Cancer & Fib

  2026-05-11

  LLY507, a highly selective SMYD2 inhibitor from APExBIO, is revolutionizing cancer and fibrosis research through its potent, selective inhibition and robust cellular activity. This guide translates recent breakthroughs—including protection against renal fibrosis—into practical workflows, troubleshooting strategies, and comparative insights for cutting-edge preclinical studies.

• Erastin: A Targeted Ferroptosis Inducer for Cancer Biology

  2026-05-10

  Erastin is a selective ferroptosis inducer that targets RAS/BRAF-mutant tumor cells through disruption of redox homeostasis. Its mechanism—modulating VDAC and inhibiting system Xc⁻—enables precise control of iron-dependent, non-apoptotic cell death. This dossier details Erastin’s validated role in ferroptosis research and practical guidance for robust experimental use.

• A23187, Free Acid: Optimizing Calcium Ionophore Workflows

  2026-05-09

  A23187, free acid empowers researchers to precisely modulate intracellular calcium and dissect complex signaling events, including apoptosis and phosphoinositide hydrolysis. This article breaks down actionable protocols, troubleshooting guides, and experimental enhancements, drawing on recent innovations in preclinical drug response evaluation and best practices for calcium ionophore assays.

• Nigericin Sodium Salt: Practical Guide for Ion Transport Stu

  2026-05-08

  Nigericin sodium salt is a potassium ionophore designed for precise manipulation of ion gradients and cytoplasmic pH in cell-based assays. It is particularly useful for researchers investigating ion transport across biological membranes, platelet aggregation modulation, and selective lead (Pb2+) ion transport. This article provides stepwise guidance for optimal use and highlights key limitations for reproducibility in the laboratory.

• Deferoxamine Mesylate: A Precision Tool for Hypoxia and Iron

  2026-05-08

  Explore how Deferoxamine mesylate, a potent iron-chelating agent, enables precise modulation of hypoxia signaling and iron metabolism in translational research. This article uniquely analyzes advanced assay design and mechanistic insights beyond ferroptosis.

476 records 13/32 page Previous Next First page 上5页 1112131415 下5页 Last page